Stem/Progenitor Cells, Atherosclerosis and Cardiovascular Regeneration

Olena Dotsenko, * Open Modal Authors Info & Affiliations
The Open Cardiovascular Medicine Journal 23 Feb 2010 RESEARCH ARTICLE DOI: 10.2174/1874192401004010097


Regenerative cell based therapy has potential to become effective adjuvant treatment for patients with atherosclerotic disease. Although data from animal studies support this notion, clinical studies undertaken in patients with acute and chronic coronary artery disease do not conclusively demonstrate benefits of such therapy. There are many questions on the stem cell translational roadmap. The basic mechanisms of stem cell-dependent tissue regeneration are not well understood. There is a debate regarding characterization of specific cell types conferring therapeutic effects. In particular, the role of endothelial progenitor cells as a specific reparative cell subtype is questioned, and the role of myeloid cell linage in fostering of vasculo- and angiogenesis is being increasingly appreciated. Intense discussions surround the place of stem/progenitor cells in atherosclerosis progression, plaque destabilization and vessel remodeling. This paper summarizes the current knowledge on the regenerative stem/progenitor cell definitions, mechanisms of stem cell trafficking, homing and their involvement in atherosclerosis progression.

Keywords: Stem cells, atherosclerosis, regenerative therapy..
Fulltext HTML PDF